Lukas Shumway
Stock Analyst at Barclays
(0.29)
# 4,579
Out of 5,088 analysts
21
Total ratings
22.2%
Success rate
-19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Lukas Shumway
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMNM Immunome | Reiterated: Buy | $36 | $18.29 | +96.83% | 6 | Oct 27, 2026 | |
| DRTS Alpha Tau Medical | Reiterated: Buy | $30 | $13.23 | +126.76% | 7 | Oct 21, 2026 | |
| STRO Sutro Biopharma | Reiterated: Buy | $56 | $9.14 | +512.69% | 5 | Oct 19, 2026 | |
| CLLS Cellectis | Downgraded: Sell | $9 → $1.3 | $1.17 | +11.11% | 3 | Sep 15, 2026 |
Immunome
Oct 27, 2026
Reiterated: Buy
Price Target: $36
Current: $18.29
Upside: +96.83%
Alpha Tau Medical
Oct 21, 2026
Reiterated: Buy
Price Target: $30
Current: $13.23
Upside: +126.76%
Sutro Biopharma
Oct 19, 2026
Reiterated: Buy
Price Target: $56
Current: $9.14
Upside: +512.69%
Cellectis
Sep 15, 2026
Downgraded: Sell
Price Target: $9 → $1.3
Current: $1.17
Upside: +11.11%